WallStSmart
SNGX

Soligenix Inc.

NASDAQ: SNGX · HEALTHCARE · BIOTECHNOLOGY

$0.35
+2.07% today

Updated 2026-04-30

Market cap
$4.34M
P/E ratio
P/S ratio
9.78x
EPS (TTM)
$-2.14
Dividend yield
52W range
$0 – $6
Volume
0.6M

Soligenix Inc. (SNGX) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-4.14M$-6.00M$-2.79M$-4.60M$-5.73M$-1.95M$-2.64M$-4.46M$-2.47M$-5.39M$-4.98M$-6.51M$-7.24M$-7.51M$-11.45M$-11.74M$-12.65M$-8.60M$-8.40M$-10.27M
Capital expenditures$208556.00$363362.00$242390.00$222529.00$336424.00$152664.00$4755.00$17728.00$50866.00$22098.00$7159.00$26348.00$1925.00$30209.00$7147.00$11789.00$13073.00$1.00$0.00$5883.00
Depreciation
Stock-based comp$522678.00$579066.00$571545.00$715805.00$493170.00$885208.00$976190.00$886693.00$574977.00$489787.00$380886.00$376339.00$409933.00$361559.00$333389.00$370182.00$329815.00$587583.00
Free cash flow$-4.35M$-6.36M$-3.03M$-4.83M$-6.07M$-2.10M$-2.64M$-4.47M$-2.52M$-5.41M$-4.99M$-6.54M$-7.25M$-7.54M$-11.46M$-11.75M$-12.66M$-8.60M$-8.40M$-10.27M
Investing cash flow
Financing cash flow
Dividends paid$0.00$0.00$0.00$0.00$0.00$0.00$0.00$43.00
Share repurchases
Debt repayment
Net change in cash$2.50M$-331148.00$-603549.00$3.85M$-963080.00$1.17M$-3.56M$13.26M